Which has the lower trailing P/E, ENSG or KRYS?

ENSG has the lower trailing P/E: ENSG trades at 27.11 and KRYS at 40.69. P/E is one valuation measure and does not by itself establish which business is cheaper.

Does ENSG or KRYS pay a bigger dividend?

ENSG pays a dividend (0.15% yield), while KRYS has no payments in the available dividend history.

Is ENSG or KRYS more profitable?

KRYS runs the higher net margin — ENSG at 6.90% versus KRYS at 54.82%.

How have ENSG and KRYS total returns compared?

Over the past 5 years, ENSG delivered 18.33% and KRYS delivered 44.28% annualized total return. Past performance doesn't predict future results.

The Ensign Group, Inc. (ENSG) vs Krystal Biotech, Inc. (KRYS)

A side-by-side comparison of The Ensign Group, Inc. and Krystal Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ENSG

The Ensign Group, Inc.

$10.08B

$172.96HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT

KRYS

Krystal Biotech, Inc.

$9.57B

$324.70HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT

Total return — ENSG vs KRYS

growth of $100 · dividends reinvested · last 9y

ENSG +830.3% (+28.1%/yr)KRYS +3047.1% (+46.7%/yr)KRYS compounded faster over this window

ENSG KRYS

ENSG vs KRYS: by the numbers

•ENSG is the larger company ($10.08B vs $9.57B market cap).
•ENSG trades at the lower trailing earnings multiple (27.11 vs 40.69 P/E), one valuation lens rather than an overall verdict.
•KRYS converts more revenue to profit (54.82% vs 6.90% net margin).
•ENSG pays a dividend (0.15% yield), while KRYS has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ENSG	KRYS
P/E ratio	27.11	40.69
Forward P/E	22.19	42.68
PEG ratio	1.96	N/A
P/S ratio	1.84	21.73
P/B ratio	4.13	7.04
EV / EBITDA	20.74	44.79
FCF yield	4.16%	2.69%

Profitability

Metric	ENSG	KRYS
Gross margin	14.14%	93.34%
Operating margin	8.52%	44.93%
Net margin	6.90%	54.82%
ROE	15.51%	17.77%
ROIC	7.29%	14.41%

Dividends

Metric	ENSG	KRYS
Dividend yield	0.15%	N/A
Payout ratio	4.04%	N/A

Growth (annualized)

Metric	ENSG	KRYS
Revenue CAGR (5Y)	17.08%	N/A
EPS CAGR (5Y)	13.47%	N/A
FCF CAGR (5Y)	10.84%	N/A
Total return CAGR (5Y)	18.33%	44.28%

Frequently asked

Which has the lower trailing P/E, ENSG or KRYS?: ENSG has the lower trailing P/E: ENSG trades at 27.11 and KRYS at 40.69. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does ENSG or KRYS pay a bigger dividend?: ENSG pays a dividend (0.15% yield), while KRYS has no payments in the available dividend history.
Is ENSG or KRYS more profitable?: KRYS runs the higher net margin — ENSG at 6.90% versus KRYS at 54.82%.
How have ENSG and KRYS total returns compared?: Over the past 5 years, ENSG delivered 18.33% and KRYS delivered 44.28% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ENSG analysis Full KRYS analysis Interactive comparison tool

Dig into the metrics

Ensign P/E ratio Krystal Biotech P/E ratio Ensign dividend yield Ensign ROE Krystal Biotech ROE Ensign operating margin Krystal Biotech operating margin Ensign revenue growth Krystal Biotech revenue growth Ensign free cash flow Krystal Biotech free cash flow

Ensign & Krystal Biotech appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.